IPO Premiums
IPO calendar
ABListed

Avience Biomedicals Limited

Bookbuilding IPO · NSE

Price band
₹196 - ₹208
Lot size
600 shares
Issue amount
₹30.24 cr
Total subscription
385.4×
Current price₹290.5
Listing price ₹395.2
Watch live price ↗
Opens
18 Jun 2026
Closes
22 Jun 2026
Allotment
23 Jun 2026
Listing
25 Jun 2026

Offer at a glance

Issue overview

Issue size
14,53,800 shares
Face value
₹10 per share
Minimum investment
₹1,17,600
Fresh issue
₹30.24 cr
Offer for sale
₹0 cr
Registrar
Skyline Financial Services Private Limited
Listing exchange
NSE
Maximum investment
₹1,24,800
Issue type
Bookbuilding IPO
Shares before issue
40,31,256
Shares after issue
54,85,056

Lot sizes

CategoryLotsSharesAmount
RETAIL21,200₹2,49,600
sHNI31,800₹3,74,400
bHNI95,400₹11,23,200

Share reservation

Anchor28.19%
QIB18.82%
HNI14.24%
RETAIL33.1%
Market Maker5.65%

Subscription & GMP

Subscription by category

Total subscribed385.4×

Reported 22 Jun 2026

QIB196.77×
NIB597.63×
RETAIL401.36×
HNIs(10L+)670.77×
HNIs(2-10L)451.35×

GMP history

05511015 Jun: ₹4215 Jun: ₹016 Jun: ₹7916 Jun: ₹5922 Jun: ₹6122 Jun: ₹5522 Jun: ₹6223 Jun: ₹6123 Jun: ₹8023 Jun: ₹6424 Jun: ₹9024 Jun: ₹110
15 Jun₹11024 Jun

Day-wise demand

18 Jun10.83×
19 Jun44.02×
22 Jun385.4×

Application-wise demand

CategoryReserved applicationsApplied applications
QIB0172
NIB031,836
RETAIL4011,60,944
HNIs(10L +)7716,492
HNIs (2-10L)3815,344

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs5.691,119.82
FIIs0195.21
FIs0139.51
Mutual Funds018.7
Others0766.4
RETAIL10.014,017.16
HNIs 2+1.44647.77
HNIs 10+2.871,925.39

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
0204060Mar-24 · Revenue: 24.37Mar-24 · Profit after tax: 2.14Mar-24Mar-25 · Revenue: 45.97Mar-25 · Profit after tax: 7.23Mar-25Jan-26 · Revenue: 41.94Jan-26 · Profit after tax: 5.74Jan-26
RevenueProfit after tax

Key performance indicators

MetricMar-26Mar-25Mar-24
EPS14.2419.066.52
ROE22.3849.8934.47
ROCE16.9924.8817.97
RONW000
PRE IPO(PE)011.590
POST IPO(PE)16.5600

Values and labels as reported in the issue data.

Company information

Company profile

Incorporated in June 2024, Avience Biomedicals Limited is an ISO-certified company engaged in the manufacturing, supply, and export of molecular diagnostic solutions for the biotechnology, genomics, and in-vitro diagnostics (IVD) sectors. The company offers a wide range of healthcare products, including rapid test kits, molecular diagnostic kits, biochemistry and hematology analyzers, medical devices, and diagnostic reagents. Its products serve pathology laboratories, hospitals, microbiology labs, and research centers in India and overseas. Along with manufacturing, the company also operates as a distributor and trader of medical equipment. Its manufacturing facility is located in Noida, Uttar Pradesh. As of January 31, 2026, Avience Biomedicals had 75 permanent employees and 33 contractual employees.

Strengths

  • Diversified Diagnostic Product Portfolio: Offers rapid test kits, analyzers, molecular diagnostics, and medical devices across multiple healthcare segments.
  • Strong Distribution Network & Market Reach: Presence across India with growing international footprint supports business expansion.
  • Quality-Focused Operations: ISO-certified processes and regulatory compliance enhance product reliability and customer trust.

Risk factors

  • Limited Operating History: Recently incorporated company with a relatively short track record.
  • Regulatory Compliance Risk: Medical devices and diagnostic products are subject to stringent approvals and regulations.
  • Dependence on Healthcare Industry Demand: Growth depends on spending by hospitals, laboratories, and healthcare institutions.

Promoters

Mr. Dharam Deo Choudhary

Mr. Ram Nagina Choudhary

Mr. Janardan Pal

Ms. Deepa Choudhary

Registrar & documents

Lead manager

Fintellectual Corporate Advisors Private Limited

Registered office

C-11, Block-C Community Centre, Janakpuri A-3, Delhi, New Delhi, 110058

1800-12-04-636

[email protected]Company website ↗

Frequently Asked Questions

What is Avience Biomedicals IPO GMP today?

As of today, Avience Biomedicals IPO Grey Market Premium (GMP) is reported at +₹90 per share. Based on the upper price band of ₹208, the estimated listing price is ₹298 (+43.3% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Avience Biomedicals IPO?

The minimum bid lot size for Avience Biomedicals IPO is 600 shares. At the cut-off price of ₹208 per share, retail investors need a minimum application amount of ₹1,24,800 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Avience Biomedicals IPO allotment status be announced?

The allotment status for Avience Biomedicals IPO is scheduled to be finalized on 23 Jun 2026. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Skyline Financial Services Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Avience Biomedicals IPO allotment status online by PAN?

To check Avience Biomedicals IPO allotment status: 1) Visit the registrar portal (Skyline Financial Services Private Limited) or the BSE IPO allotment page. 2) Select 'Avience Biomedicals Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Avience Biomedicals IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums